Hello everyone! Today we’re thrilled to recommend an in-depth sharing session brought to you by our partner, OCT CRO. If you’re keeping a close eye on the pharmaceutical market in Russia and the EAEU, this live webinar is a must-attend.
01 Core Content
This webinar will provide an overview of the regulatory landscape for clinical trials and drug registration in Russia and the Eurasian Economic Union (EAEU).
Key highlights include the EAEU’s specific requirements, such as the necessity of local clinical trials, the upcoming Good Clinical Practice (GCP) inspections to be implemented in 2026, and the Union’s common format for the Common Technical Document (CTD).
The session will also explore special registration pathways, orphan drug designation, and the latest regulatory updates. You’ll gain practical insights to help your enterprise navigate the evolving regulatory framework and support successful market access and compliant operations in the region.
Agenda:
a. A detailed breakdown of the policies and specific procedures for clinical trials and drug registration within the EAEU;
b. Guidance for enterprises on conducting clinical trials and entering the markets of Russia and other EAEU member states;
c. Registration strategies for biological products, chemical pharmaceuticals and herbal medicines;
d. Local regulatory systems.
Live Session Start Time: 15:00, March 3rd
Scan the QR code to register and reserve your spot!
02 Speakers
Irina Petrova, MD
Head of Clinical Operations, OCT CRO
Dr. Irina Petrova is a graduate of Saint Petersburg State Pavlov Medical University, one of Russia’s most prestigious medical institutions. She entered the drug development industry 25 years ago and has since dedicated her career to clinical research. Having managed projects across multiple therapeutic areas, she has led the Clinical Department at OCT CRO since 2008.
Endowed with extensive industry experience and a regular presence at cutting-edge industry conferences and therapeutic area symposia, Dr. Petrova is recognized as an expert in all aspects of clinical trial implementation and drug registration. Her expertise covers the nuances of local regulatory requirements, details of regulatory submissions, site selection and activation, data collection and processing, trial design, EAEU marketing authorization, as well as the logistics management of investigational medicinal products and biological samples.
Evgenia Radkova, MD
Head of Medical Science Consulting and Excellence Center, OCT CRO
Dr. Evgenia Radkova joined OCT Clinical in 2013. She is responsible for providing professional expertise and guidance on all matters related to the scientific methodology and design of clinical trials, as well as developing the full suite of medical documentation (including study protocols, informed consent forms, investigator’s brochures and clinical study reports). She boasts extensive experience in Phase I-IV interventional studies and observational epidemiological research.
Her research experience and professional acumen enable her to successfully address a wide range of challenges in drug development and clinical research. Dr. Radkova is a member of the European Medical Writers Association (EMWA) and the American Medical Writers Association (AMWA). She regularly enhances her professional skills in medical and regulatory writing, biostatistics, methodology and clinical trial design through various training courses.
Live Session Start Time: 15:00, March 3rd
Scan the QR code to register and reserve your spot!
03 About OCT CRO
OCT CRO is a full-service Contract Research Organization (CRO) with 20 years of market experience. Specializing in the design, execution of clinical trials and drug registration, the company has conducted over 360 studies across multiple therapeutic areas in Russia, the Eurasian Economic Union (EAEU) and Eastern Europe.
Its team comprises 140 professionals, including 35 Medical Doctors and 30 specialists with degrees in pharmacy or biology.
For more information, please visit: https://oct-cro.com/en/
